Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons
Neurobiology of Disease · 2025
DOI: 10.1016/j.nbd.2025.107016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Sara Naya-Forcano und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain. Hauptthemen laut MEDLINE: Sphingomyelin Phosphodiesterase, Receptors, Glucocorticoid, Neurons, Neuronal Plasticity. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acid sphingomyelinase deficiency (ASMD) is a rare disease caused by mutations in the gene encoding ASM, an enzyme that degrades sphingomyelin (SM). In addition to SM accumulation, neuroinflammation and cognitive impairment are pathological hallmarks of neurovisceral ASMD. Since the glucocorticoid system may influence these features, we have characterized it in ASM knockout (ASMko) mice that mimic this form of the disease. While plasma corticosterone levels are not altered in these mice, brain levels of the α, but not the β, isoform of glucocorticoid receptors (GR) are reduced. The reduction is evident in neurons and is due to the accumulation of SM. As a consequence, the expression of the protein, synapsin I, is low in ASMko neurons, leading to the disorganization of synaptic vesicles and to impaired presynaptic plasticity. Treatment with the glucocorticoid hydrocortisone diminished SM levels, increased synapsin I expression, and improved presynaptic function in neuronal cultures and hippocampal slices of ASMko mice. These findings establish, for the first time, a link between the glucocorticoid system and brain pathology in ASMD, highlighting the GR as a potential therapeutic target for this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain.
- Department of Psychobiology, UNED, Madrid, Spain.
- Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Centro Biología Molecular Severo Ochoa (CSIC-UAM), 28049 Madrid, Spain. Electronic address: dledesma@cbm.csic.es.
Zitieren
APA
Naya-Forcano, S., Gaudioso, Á., Soto-Huelin, B., García-Vilela, C., Venero, C., Schuchman, E. H., Esteban, J. A., & Ledesma, M. D. (2025). Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.107016
Vancouver
Naya-Forcano S, Gaudioso Á, Soto-Huelin B, García-Vilela C, Venero C, Schuchman EH, et al. Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.107016
BibTeX
@article{NayaForcano2025,
author = {Naya-Forcano, Sara and Gaudioso, Ángel and Soto-Huelin, Beatriz and García-Vilela, Celia and Venero, César and Schuchman, Edward H and Esteban, José A and Ledesma, María Dolores},
title = {Sphingomyelin-induced glucocorticoid receptor alterations lead to impaired presynaptic plasticity in acid sphingomyelinase deficient neurons},
journal = {Neurobiology of Disease},
year = {2025},
doi = {10.1016/j.nbd.2025.107016}
}
EUVIMED